CMT Research Foundation invests in research project to develop treatments for CMTs
The rare, peripheral neuropathy disease affects nearly three million people globally
Read More
Tag: peripheral neuropathy disease
CMT Research Foundation funds study investigating treatment for CMT1X disease
X-linked Charcot-Marie-Tooth is the second most common form of the rare peripheral neuropathy disease
Read More
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
